181 related articles for article (PubMed ID: 30935255)
1. Patients opinion and adherence to antimalarials in lupus erythematosus and rheumatoid arthritis treatment.
Cabral RTS; Klumb EM; Carneiro S
J Dermatolog Treat; 2020 May; 31(3):264-269. PubMed ID: 30935255
[No Abstract] [Full Text] [Related]
2. Evaluation of toxic retinopathy caused by antimalarial medications with spectral domain optical coherence tomography.
Cabral RTS; Klumb EM; Couto MINN; Carneiro S
Arq Bras Oftalmol; 2019; 82(1):12-17. PubMed ID: 30403262
[TBL] [Abstract][Full Text] [Related]
3. Fatal antimalarial-induced cardiomyopathy: report of 2 cases.
Azimian M; Gultekin SH; Hata JL; Atkinson JB; Ely KA; Fuchs HA; Mobley BC
J Clin Rheumatol; 2012 Oct; 18(7):363-6. PubMed ID: 23047537
[TBL] [Abstract][Full Text] [Related]
4. [Antimalarial's retinopaty remains a current threat].
Chiffoleau A; Guillet A; Zanlonghi X; Jolliet P
Presse Med; 2009 Apr; 38(4):662-3. PubMed ID: 19135848
[No Abstract] [Full Text] [Related]
5. Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.
Spinelli FR; Moscarelli E; Ceccarelli F; Miranda F; Perricone C; Truglia S; Garufi C; Massaro L; Morello F; Alessandri C; Valesini G; Conti F
Lupus; 2018 Sep; 27(10):1616-1623. PubMed ID: 29954281
[TBL] [Abstract][Full Text] [Related]
6. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
[No Abstract] [Full Text] [Related]
7. Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients.
Silva JC; Mariz HA; Rocha LF; Oliveira PS; Dantas AT; Duarte AL; Pitta Ida R; Galdino SL; Pitta MG
Clinics (Sao Paulo); 2013 Jun; 68(6):766-71. PubMed ID: 23778483
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
Aylward JM
J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine, Hydroxychloroquine and Hearing Loss: A Study in Systemic Lupus Erythematosus Patients.
Polanski JF; Tanaka EA; Barros H; Chuchene AG; Miguel PTG; Skare TL
Laryngoscope; 2021 Mar; 131(3):E957-E960. PubMed ID: 32603516
[TBL] [Abstract][Full Text] [Related]
10. Long-term effectiveness of antimalarial drugs in rheumatic diseases.
Aviña-Zubieta JA; Galindo-Rodriguez G; Newman S; Suarez-Almazor ME; Russell AS
Ann Rheum Dis; 1998 Oct; 57(10):582-7. PubMed ID: 9893568
[TBL] [Abstract][Full Text] [Related]
11. Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus--a case report.
Bogaczewicz J; Sobów T; Bogaczewicz A; Robak E; Bienkowski P; Sysa-Jedrzejowska A; Wozniacka A
Lupus; 2014 Feb; 23(2):188-93. PubMed ID: 24297641
[TBL] [Abstract][Full Text] [Related]
12. More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus.
Pakchotanon R; Gladman DD; Su J; Urowitz MB
J Rheumatol; 2018 Jan; 45(1):90-94. PubMed ID: 29142038
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial treatment of rheumatoid arthritis: 1985 status.
Rynes RI
J Rheumatol; 1985 Aug; 12(4):657-9. PubMed ID: 4057186
[No Abstract] [Full Text] [Related]
14. Keratopathy with low dose chloroquine therapy.
Cullen AP; Chou BR
J Am Optom Assoc; 1986 May; 57(5):368-72. PubMed ID: 3711574
[TBL] [Abstract][Full Text] [Related]
15. [Current view on chloroquine derivative treatment from rheumatologist perspective and possible ocular side effects].
Pawlak-Buś K; Gaca-Wysocka M; Grzybowski A; Leszczyński P
Pol Merkur Lekarski; 2016 Mar; 40(237):202-6. PubMed ID: 27088206
[TBL] [Abstract][Full Text] [Related]
16. Current practice in antimalarial drug prescribing in rheumatoid arthritis.
Bellamy N; Brooks PM
J Rheumatol; 1986 Jun; 13(3):551-5. PubMed ID: 3735276
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases.
Bahloul E; Jallouli M; Garbaa S; Marzouk S; Masmoudi A; Turki H; Bahloul Z
Lupus; 2017 Oct; 26(12):1304-1308. PubMed ID: 28355984
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial treatment of rheumatoid arthritis.
Zvaifler NJ
Med Clin North Am; 1968 May; 52(3):759-64. PubMed ID: 5653948
[No Abstract] [Full Text] [Related]
19. [Eye toxicity of antimalarial agents].
Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial drug retinopathy: A typical « Bull's eyes » appearance of fundus.
Guiot A; Couturier M; Tebib JG; Abouaf L; Coury F
Joint Bone Spine; 2018 May; 85(3):369. PubMed ID: 28512007
[No Abstract] [Full Text] [Related]
[Next] [New Search]
